Cytodyn Inc (CYDY)

[JPG77]

Misiu - I've been around here for a while, but there's still one thing that I'm missing, and I hope that you can help explain it given your medical background. As I understand it, the adjunct trial requires the patient to stay on their HAART meds while taking Pro140. So, what is the benefit for these patients to enroll in the adjunct trail and take Pro140 if they're still going to suffer the side effects from their HAART medication? Just curious as to whether this may be one of the reasons why it's been difficult for their CRO to find patients who are willing to enroll in the adjunct trial if there's no real benefit to going to the trial site every week and getting an injection. I understand their viral load may be less, but is that enough incentive?